- Home
- NOG vs KYMR Comparison
NOG vs KYMR Comparison
Compare NOG & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- KYMR
- Stock Information
- Founded
- NOG 2006
- KYMR 2015
- Country
- NOG United States
- KYMR United States
- Employees
- NOG N/A
- KYMR N/A
- Industry
- NOG Oil & Gas Production
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- NOG Energy
- KYMR Health Care
- Exchange
- NOG Nasdaq
- KYMR Nasdaq
- Market Cap
- NOG 2.8B
- KYMR 3.1B
- IPO Year
- NOG N/A
- KYMR 2020
- Fundamental
- Price
- NOG $24.35
- KYMR $42.63
- Analyst Decision
- NOG Buy
- KYMR Strong Buy
- Analyst Count
- NOG 8
- KYMR 16
- Target Price
- NOG $36.25
- KYMR $58.94
- AVG Volume (30 Days)
- NOG 1.9M
- KYMR 622.1K
- Earning Date
- NOG 07-31-2025
- KYMR 08-11-2025
- Dividend Yield
- NOG 7.39%
- KYMR N/A
- EPS Growth
- NOG 6.84
- KYMR N/A
- EPS
- NOG 6.08
- KYMR N/A
- Revenue
- NOG $2,094,039,000.00
- KYMR $44,711,000.00
- Revenue This Year
- NOG $11.88
- KYMR $58.26
- Revenue Next Year
- NOG N/A
- KYMR N/A
- P/E Ratio
- NOG $4.00
- KYMR N/A
- Revenue Growth
- NOG 6.25
- KYMR N/A
- 52 Week Low
- NOG $19.88
- KYMR $19.45
- 52 Week High
- NOG $44.31
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- NOG 36.05
- KYMR 49.94
- Support Level
- NOG $24.21
- KYMR $36.65
- Resistance Level
- NOG $25.04
- KYMR $44.94
- Average True Range (ATR)
- NOG 1.17
- KYMR 1.64
- MACD
- NOG -0.14
- KYMR -0.18
- Stochastic Oscillator
- NOG 7.64
- KYMR 72.14
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.